Invesque Inc. (TSE:IVQ – Get Free Report) shares rose 3.8% on Wednesday . The company traded as high as C$0.14 and last traded at C$0.14. Approximately 6,000 shares were traded during trading, a decline of 64% from the average daily volume of 16,872 shares. The stock had previously closed at C$0.13.
Invesque Stock Performance
The firm has a market capitalization of C$7.58 million, a price-to-earnings ratio of -0.11 and a beta of 1.40. The company has a 50-day moving average price of C$0.13 and a 200-day moving average price of C$0.17. The company has a quick ratio of 0.35, a current ratio of 0.77 and a debt-to-equity ratio of 471.30.
Invesque (TSE:IVQ – Get Free Report) last announced its quarterly earnings results on Thursday, November 7th. The company reported C($0.17) earnings per share (EPS) for the quarter. Invesque had a negative return on equity of 36.28% and a negative net margin of 33.48%. The business had revenue of C$57.82 million for the quarter. As a group, equities research analysts forecast that Invesque Inc. will post 0.63 earnings per share for the current year.
About Invesque
Invesque Inc operates as a health care real estate company in North America. The company's investment property portfolio includes investments in independent living, assisted living, memory care, skilled nursing, and transitional care properties. It also includes investments in owner occupied seniors housing properties, including the ownership of real estate properties, as well as provides management services.
Featured Articles
- Five stocks we like better than Invesque
- Investing In Preferred Stock vs. Common Stock
- Novo Nordisk: A New Boost for GLP-1 Sales on the Horizon
- 3 Monster Growth Stocks to Buy Now
- Why Now Is the Ultimate Time to Invest in Oil Stocks
- Stock Analyst Ratings and Canadian Analyst Ratings
- Q4’s Most Upgraded Stocks: Promising Buys for 2025
Receive News & Ratings for Invesque Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Invesque and related companies with MarketBeat.com's FREE daily email newsletter.